Monument Capital Management Brainstorm Cell Therapeutics Inc. Transaction History

Monument Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$2.98 - $3.9 $992 - $1,298	-333 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$3.73 - $4.38 $1,242 - $1,458	333 New	333 $1,000
Q3 2018 Oct 11, 2018	SELL	$3.73 - $4.38 $1,242 - $1,458	-333 Closed	0 $0
Q4 2017 Feb 05, 2018	BUY	$2.96 - $4.42 $985 - $1,471	333	333 $1,000

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $82.8M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Monument Capital Management, based on Form 13F filings with the SEC.

Stay updated on Monument Capital Management with notifications on news.